These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26125505)

  • 1. Sex difference in presentation and outcomes of bladder cancer: biological reality or statistical fluke?
    Wolff I; Brookman-May S; May M
    Curr Opin Urol; 2015 Sep; 25(5):418-26. PubMed ID: 26125505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.
    May M; Burger M; Brookman-May S; Stief CG; Fritsche HM; Roigas J; Zacharias M; Bader M; Mandel P; Gilfrich C; Seitz M; Tilki D
    Clin Genitourin Cancer; 2014 Aug; 12(4):278-86. PubMed ID: 24331576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
    Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ
    BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review.
    Rouprêt M; Seisen T; Compérat E; Larré S; Mazerolles C; Gobet F; Fetissof F; Fromont G; Safsaf A; d'Arcier BF; Celhay O; Validire P; Rozet F; Irani J; Soulié M; Pfister C;
    J Urol; 2013 Jun; 189(6):2069-76. PubMed ID: 23201497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.
    Dobruch J; Daneshmand S; Fisch M; Lotan Y; Noon AP; Resnick MJ; Shariat SF; Zlotta AR; Boorjian SA
    Eur Urol; 2016 Feb; 69(2):300-10. PubMed ID: 26346676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female bladder cancer: incidence, treatment, and outcome.
    Scosyrev E; Trivedi D; Messing E
    Curr Opin Urol; 2010 Sep; 20(5):404-8. PubMed ID: 20592613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment delay and prognosis in invasive bladder cancer.
    Liedberg F; Anderson H; Månsson W
    J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.
    Kim K; Cho YM; Park BH; Lee JL; Ro JY; Go H; Shim JW
    Int J Clin Exp Pathol; 2015; 8(1):743-50. PubMed ID: 25755769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
    Berman DM; Kawashima A; Peng Y; Mackillop WJ; Siemens DR; Booth CM
    Int J Urol; 2015 Feb; 22(2):163-70. PubMed ID: 25197026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for survival in patients with recurrence of muscle invasive bladder cancer after treatment with curative intent.
    Ploeg M; Kums AC; Aben KK; van Lin EN; Smits G; Vergunst H; Viddeleer AC; Geboers AD; van Berkel H; van Boven E; Kiemeney LA; Witjes F
    Clin Genitourin Cancer; 2011 Sep; 9(1):14-21. PubMed ID: 21723794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term trends in sex difference in bladder cancer survival 1975-2009: A population-based study in Osaka, Japan.
    Aoe J; Ito Y; Fukui K; Nakayama M; Morishima T; Miyashiro I; Sobue T; Nakayama T
    Cancer Med; 2020 Oct; 9(19):7330-7340. PubMed ID: 32794368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K; Kawakami S; Fujii Y; Sakura M; Masuda H; Kihara K
    J Urol; 2007 Dec; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.
    Gray PJ; Fedewa SA; Shipley WU; Efstathiou JA; Lin CC; Zietman AL; Virgo KS
    Eur Urol; 2013 May; 63(5):823-9. PubMed ID: 23200811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and Racial Disparities in the Treatment and Outcomes of Muscle-invasive Bladder Cancer.
    Marinaro J; Zeymo A; Egan J; Carvalho F; Krasnow R; Stamatakis L; Lynch J; Hwang J; Williams S; Kowalczyk K
    Urology; 2021 May; 151():154-162. PubMed ID: 32810481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
    Aziz A; Gierth M; Fritsche HM; May M; Otto W; Denzinger S; Wieland WF; Merseburger A; Riedmiller H; Kocot A; Burger M
    Urol Int; 2013; 91(1):97-102. PubMed ID: 23751372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sex on prognosis of urothelial carcinoma: propensity score matching analysis.
    Choo MS; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2015 Apr; 13(2):e113-21. PubMed ID: 25456840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.